4//SEC Filing
Sahmoud Tarek 4
Accession 0001842952-22-000075
CIK 0001842952other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:31 PM ET
Size
5.6 KB
Accession
0001842952-22-000075
Insider Transaction Report
Form 4
Sahmoud Tarek
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-12+25,000→ 25,000 totalExercise: $1.96Exp: 2032-08-11→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001861811
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:31 PM ET
- Size
- 5.6 KB